Literature DB >> 7225167

Serum lipids, lipoprotein lipids and coronary heart disease in patients with xanthelasma palpebrarum.

A Watanabe, A Yoshimura, T Wakasugi, R Tatami, K Ueda, R Ueda, T Haba, T Kametani, J Koizumi, S Ito, M Ohta, S Miyamoto, H Mabuchi, R Takeda.   

Abstract

Serum lipids and lipoprotein lipids were studied in 53 patients (21 males and 32 females) with xanthelasma palpebrarum and 40 age-matched normal controls (20 males and 20 females). Patients were subdivided into patients with normolipidemia, hyperlipidemia or familial hypercholesterolemia (FH). In both male and female patients with hyperlipidemia or FH, the serum cholesterol (Chol) levels were significantly higher than in normal controls. In both male and female patients with normolipidemia or hyperlipidemia, the VLDL-Chol levels were significantly higher than in normal controls. Male patients with FH showed significantly higher levels of VLDL-Chol than normal controls. Both male and female patients with normolipidemia, hyperlipidemia or FH showed significantly higher levels of LDL-Chol, lower HDL-Chol levels and lower HDL-Chol/LDL-Chol ratios than normal controls. In both male and female patients with hyperlipidemia and in male patients with FH, the serum triglyceride (TG) levels were significantly higher than in normal controls. Both male and female hyperlipidemic patients showed significantly higher levels of VLDL-TG than normal controls. In male patients with FH, the VLDL-TG levels were significantly above the control levels. In male patients with normolipidermia, the LDL-TG levels were significantly higher than in normal controls. In both male and female patients with hyperlipidemia or FH, the LDL-TG levels were significantly higher than in normal controls. The HDL-TG levels in patients with normolipidemia (males) or FH (females) were significantly lower than in normal controls. The prevalence of coronary heart disease in patients with normolipidemia, hyperlipidemia or FH was 29.4%, 24.0% and 45.4%, respectively.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7225167     DOI: 10.1016/0021-9150(81)90044-7

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  7 in total

1.  Xanthelasma Palpebrarum-clinical and biochemical profile in a tertiary care hospital of Delhi.

Authors:  A Jain; P Goyal; P K Nigam; H Gurbaksh; R C Sharma
Journal:  Indian J Clin Biochem       Date:  2007-09

2.  Xanthelasma Palpebrarum: More than Meets the Eye.

Authors:  Shailesh Khode; Soon Heng Terry Tan; En-Pei Amanda Tan; Sandeep Uppal
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-04-07

3.  Dyslipidemia and H pylori in gastric xanthomatosis.

Authors:  Sun Young Yi
Journal:  World J Gastroenterol       Date:  2007-09-14       Impact factor: 5.742

4.  Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study.

Authors:  Mette Christoffersen; Ruth Frikke-Schmidt; Peter Schnohr; Gorm B Jensen; Børge G Nordestgaard; Anne Tybjærg-Hansen
Journal:  BMJ       Date:  2011-09-15

5.  Familial xanthelasma with dyslipidemia: just another family trait?

Authors:  Shridhar Dwivedi; Amitesh Aggarwal; Safal Singh; Vishal Sharma
Journal:  N Am J Med Sci       Date:  2012-05

6.  Risk of Non-Alcoholic Fatty Liver Disease in Xanthelasma Palpebrarum.

Authors:  Ying-Hsuen Wu; Yi-Lin Chiu; Hsuan-Wei Chen; Jung-Chun Lin
Journal:  J Inflamm Res       Date:  2021-05-12

7.  Xanthelasma Palpebrarum with Arcus Cornea: A Clinical and Biochemical Study.

Authors:  Pragya Ashok Nair; Chaitali R Patel; Jaishree D Ganjiwale; Nilofar Gulamsha Diwan; Nidhi Bhimjibhai Jivani
Journal:  Indian J Dermatol       Date:  2016 May-Jun       Impact factor: 1.494

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.